MARKET

CRL

CRL

Charles Riv Labs Intl Inc
NYSE
208.41
-1.06
-0.51%
Closed 17:05 06/17 EDT
OPEN
208.23
PREV CLOSE
209.47
HIGH
209.06
LOW
207.02
VOLUME
396.62K
TURNOVER
0
52 WEEK HIGH
275.00
52 WEEK LOW
161.65
MARKET CAP
10.74B
P/E (TTM)
24.45
1D
5D
1M
3M
1Y
5Y
Weekly Report: what happened at CRL last week (0610-0614)?
Weekly Report · 1d ago
Tracking John Rogers' Ariel Investments Portfolio - Q1 2024 Update
Seeking Alpha · 6d ago
Charles River Laboratories In Collaboration With MatTek Awarded $1.3M Grant From The Foundation For Chemistry Research And Initiatives To Advance Research Alternatives
Project will utilize an integrated approach to develop an in vitro alternative to inhalation toxicology studies. $1.3 million grant from the Foundation for Chemistry Research & Initiatives. Charles River Laboratories International to develop a New Approach Methodology to reduce reliance on animal research methods.
Benzinga · 6d ago
Charles River (CRL) Partners to Reduce Animal Research Usage
NASDAQ · 6d ago
Charles River Laboratories International Insiders Sell US$6.2m Of Stock, Possibly Signalling Caution
Charles River Laboratories International, Inc. Insiders have sold more shares than they bought in the last year. The biggest insider sale was US$1.3m worth of shares at US$254 per share. In the last three months, there was significant insider selling at Charles River Laboratories international. The company owns 1.1% of Charles River Labs International. But the company may not be the best stock to buy. You can see the insider transactions at charles river labs labradorinternational.com.
Simply Wall St · 06/10 11:07
Weekly Report: what happened at CRL last week (0603-0607)?
Weekly Report · 06/10 09:20
Mizuho starts Charles River Labs at neutral, cites near-term challenges
Healthcare Mizuho starts Charles River Labs at neutral, cites near-term challenges. The investment bank set a price target of $235 for the stock. Charles River Laboratories International, Inc. (CRL) has a market cap of $1.2 billion.
Seeking Alpha · 06/07 17:11
Charles River Labs Initiated at Neutral by Mizuho
Dow Jones · 06/07 10:52
More
About CRL
Charles River Laboratories International, Inc. provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and academic institutions around the globe accelerate their research and drug development efforts. The Company's Research Models and Services segment is comprised of three businesses that provide foundational tools that enables its clients to discover new molecules: Research Models, Research Model Services, and Cell Solutions. Its Discovery and Safety Assessment segment provides regulated and non-regulated DSA services to support the research, development, and regulatory-required safety testing of potential new drugs, including therapeutic discovery and optimization plus in vitro and in vivo studies, laboratory support services, and strategic non-clinical consulting and program management to support product development. Its Manufacturing Solutions segment includes Microbial Solutions and Biologics Solutions.

Webull offers Charles River Lbrtrs ntrntl Inc stock information, including NYSE: CRL real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CRL stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading CRL stock methods without spending real money on the virtual paper trading platform.